Former pharmaceutical co. CEO Martin Shkreli faces fraud trial

INTRO:

Former pharmaceutical company CEO Martin Shkreli is facing trial for
lying to investors in his hedge fund and paying them off with millions
of dollars in cash from the company Retrophin Inc.

The so-called "pharma bro" raised the price of a generic drug by 5000
percent sparking major controversy 2 years ago.

Our US correspondent Laura Cantekin reports from New York.

IN: "Back in 2015...
OUT: SOC
DUR: 44

938LIVE: http://www.fsnradionews.com/feeds/0625pharmabro-lc-938live.mp3
AIR: http://www.fsnradionews.com/feeds/0625pharmabro-lc-air.mp3
ARN: http://www.fsnradionews.com/feeds/0625pharmabro-lc-arn.mp3
FM4: http://www.fsnradionews.com/feeds/0625pharmabro-lc-fm4.mp3
GENERIC: http://www.fsnradionews.com/feeds/0625pharmabro-lc-generic.mp3
ICRT: http://www.fsnradionews.com/feeds/0625pharmabro-lc-icrt.mp3
NIGERIA: http://www.fsnradionews.com/feeds/0625pharmabro-lc-von.mp3
RNZ: http://www.fsnradionews.com/feeds/0625pharmabro-lc-rnz.mp3
SRN: http://www.fsnradionews.com/feeds/0625pharmabro-lc-srn.mp3
VATICAN: http://www.fsnradionews.com/feeds/0625pharmabro-lc-vat.mp3
ZIZ: http://www.fsnradionews.com/feeds/0625pharmabro-lc-ziz.mp3